Autopsy report · NCT02848716
Pretherapeutic Paraaortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Versus Definitive Chemoradiotherapy
Cause of deathStaffing, sites or logistics
“Study cancelled due to operational difficulties”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 3
- Sponsor
- Muriel POUBLANC
- Sponsor type
- University, hospital or other
- Conditions
- Overall Survival Comparison Between the 2 Arms
- Interventions
- Surgery followed with chemoradiation; Standard chemoradiation; chemoradiation
- Participants
- 0
Trials that died the same way
- Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
“Study was terminated due to administrative reasons” - Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer
“Study was terminated due to lack of accrual” - An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections
“Study was prematurely terminated due to administrative and strategic reasons” - Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer
“Study was terminated due to poor accrual” - Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses
“Study was terminated due to a business decision to cancel the entire project.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.